NAMWOLF Lauds Jeffrey B. Kindler’s Appointment as CEO at Pfizer Inc.

The National Association of Minority and Women Owned Law Firms (NAMWOLF) congratulates Jeffrey B. Kindler on his recent appointment as Chief Executive Officer and his election to Pfizer’s Board of Directors. Mr. Kindler succeeds Hank McKinnell, who will continue as Pfizer’s Chairman of the Board until his retirement in February, 2007.

Milwaukee, WI (PRWEB) August 10, 2006 -- The National Association of Minority and Women Owned Law Firms (NAMWOLF) congratulates Jeffrey B. Kindler on his recent appointment as Chief Executive Officer and his election to Pfizer’s Board of Directors. Mr. Kindler succeeds Hank McKinnell, who will continue as Pfizer’s Chairman of the Board until his retirement in February, 2007.

“Pfizer Inc. should be commended for their selection of Jeffrey B. Kindler as Chief Executive Officer,” said Yolanda Coly, Associate Director of NAMWOLF. “Mr. Kindler has an impressive record of working to increase diversity and with his newly appointed position, Pfizer has great leadership for years ahead,” she added.

Mr. Kindler joined Pfizer in 2002 as Senior Vice President and General Counsel. Mr. Kindler continues as Pfizer Inc's Vice Chairman and General Counsel while also serving as Chief Executive Officer.

The National Association of Minority & Women Owned Law Firms (www.namwolf.org) was founded in June, 2001. It is a national trade association comprising a select group of minority and women-owned law firms who exhibit excellence in the legal profession. The primary aim of the organization is to advocate for the increased utilization of minority and women-owned law firms by major corporations and public entities throughout the United States.

# # #